What is the treatment for Urinary Tract Infection (UTI) in pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For treating urinary tract infections (UTIs) in pregnant women, first-line therapy is typically nitrofurantoin 100mg twice daily for 5-7 days, except in the first trimester and near delivery. Alternatives include amoxicillin-clavulanate 500/125mg twice daily for 5-7 days or cephalexin 500mg four times daily for 5-7 days 1. Fosfomycin 3g as a single dose is also safe during pregnancy, but its effectiveness in preventing adverse outcomes such as pyelonephritis and preterm labor is not yet well studied 1. Trimethoprim-sulfamethoxazole should be avoided in the first trimester due to folate antagonism and near term due to risk of neonatal hyperbilirubinemia. Fluoroquinolones and tetracyclines are contraindicated throughout pregnancy.

Key Considerations

  • Asymptomatic bacteriuria should also be treated in pregnancy as it increases the risk of pyelonephritis, preterm birth, and low birth weight 1.
  • Urine culture should be obtained before treatment to guide antibiotic selection, and a test of cure should be performed 1-2 weeks after completing therapy.
  • Increased fluid intake and urinating after intercourse may help prevent recurrence.
  • UTIs in pregnancy require prompt treatment as they can ascend to the kidneys more easily due to pregnancy-related physiological changes including urinary stasis from progesterone effects and mechanical compression of the ureters.

Special Populations

  • Diabetic women with asymptomatic bacteriuria do not benefit from screening or treatment, and may experience harm from antimicrobial therapy 1.
  • The optimal duration of antimicrobial therapy for treatment of bacteriuria in pregnant women has not been determined, but current recommendations for a 4- to 7-day duration are reasonable 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Treatment Options for UTI in Pregnancy

  • The recommended treatment for urinary tract infection (UTI) in pregnancy includes separating pregnant subjects with UTI into two groups: those with asymptomatic bacteriuria and those with symptomatic UTI 2.
  • For asymptomatic bacteriuria, a single dose of an antimicrobial to which the organism is susceptible can be used, while for symptomatic UTI, amoxicillin 500 mg tid for three days is recommended 2.
  • Other treatment options include nitrofurantoin, trimethoprim/sulfamethoxazole, and cephalosporins, although the cure rates may vary 2.

International Guidelines for UTI Treatment in Pregnancy

  • A literature review of international guidelines for UTI treatment in pregnancy found concordance between guidelines on several aspects, including the use of antibiotics and follow-up after treatment 3.
  • However, there are areas of discordance, such as the use of fluoroquinolones in lower or upper UTI 3.

Current Prescribing Practices for UTI Treatment

  • A study on current prescribing practices for uncomplicated UTI treatment in women found that guideline discordance continues, with the overuse of fluoroquinolones and underuse of first-line antibiotic agents 4.
  • The study also found that obstetricians-gynecologists and urologists had a higher likelihood of concordant treatment than other specialties 4.

Nitrofurantoin as a Treatment Option

  • Nitrofurantoin is a wide-spectrum antibiotic that is commonly used to treat UTIs and has been repositioned as first-line therapy for uncomplicated lower UTI 5.
  • A narrative review found that nitrofurantoin can be considered the most effective drug in the treatment of acute urinary infection, but its long-term side effects, especially in elderly patients, need to be considered 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.